MAOB and Hepatic fibrosis: Numerous investigations have identified elevated MAO-B levels in the serum of patients with early liver fibrosis, rendering it an ideal biomarker for early fibrosis diagnosis (Walker and Edmondson, 1994; Park et al., 2019).